WuRevue Week Ending 10/02/2020
posted October 3, 2020
Top News:
9/28: The U.S. has reportedly tightened restrictions on exports of key semiconductor supplies to China, thwarting the latter’s ambition in achieving technological autonomy.
9/29: Snapping a two-month downward streak, consumer confidence bounced back sharply to a post-pandemic high in September. House Democrats are slated to discuss its newly-unveiled $2.2T relief bill with the White House. In Europe, negotiations have resumed in a last-ditch effort to avoid a no-deal Brexit.
9/30: A trio of upbeat economic releases (here, here and here) helped assuage investors’ indelibly bitter aftertaste from the “incongruously small and unbefitting” presidential debate. Recovery in China’s overall economy continued to pick up steam in September. In a move similar to the Fed, the ECB is undertaking a “strategy review,” in light of heightened concerns over deflation.
10/01: Rumors swirled around the fate of the follow-up economic stimulus bill mired in last-gasp negotiations. While the weekly jobless claims report painted a recovering labor market, strains remained evident as at least 26.5 million Americans received benefits through various schemes. U.S. consumer spending rose 1% in August, even as income fell 2.7% due to the expiration of unemployment supplement in July. U.S. manufacturing grew for the fifth consecutive month in September, albeit at a slightly slower clip.
10/02: September’s hiring pace moderated as unemployment rate stood at 7.9%, while revelation of the U.S. president’s Covid diagnosis compounded market uncertainty. The House passed a $2.2T economic relief bill, notwithstanding stalled bipartisan talks.
Heard on the Street:
“I’m a monetary theorist. This is what I teach and study. This is unprecedented in 75 years, since World War II. I think there’s a lot of repressed liquidity in the market that once the vaccine and the pandemic fears fade in 2021, we’re going to see a big boost in activity.”
— Prof. Jeremy Siegel, University of Pennsylvania, as quoted by CNBC on 9/28/2020
“Perhaps the only point worth mentioning is that the debate may have increased expectations for a contested election result. International investors have been prepared to entertain some extreme views on this topic (just as they entertained extreme views on the future of the euro area in the past). Given the importance of international investors to U.S. markets, this may add volatility around the election.”
— Paul Donovan, chief economist at UBS Global Wealth Management, as quoted by MarketWatch on 9/30/2020
Longer Game:
Nouriel Roubini, nicknamed “Dr. Doom” by the media, dispelled the long-held myth Republicans are better than Democrats at economic stewardship and explained his choice in the upcoming election.
Bonus:
Medical researchers continue to make encouraging, incremental progress on both treatment (here) and vaccine fronts (here) against Covid-19. However, for one frontrunning vaccine candidate in late trials, distribution to the general public is not expected until spring 2021.